PATENT CLAIM ANALYSIS

Application Number: 16108346
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["435", "060000"]

Abstract:
Disclosed herein are compounds that inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases using the compounds.

Claim (Index 6):
A method of treating systemic lupus erythematosus, lupus nephritis, or Sjogren's Syndrome in a subject in need of treatment, said method comprising administering to the subject a therapeutically effective amount of a compound of  claim 1  or a therapeutically acceptable salt of the compound of  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 96.0
- Lexical Diversity: 1.2381
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['12787682', '12951344', '13831184', '14038304', '15136582']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7646455982268424
- 35 USC 102 Novelty (BERT): 0.613694004753186
- Combined Prediction Score: 0.7495504388794768
- Mean Citation Score: 674.231376
- Max Citation Score: 683.8873
- Similarity Product: 485.4282635260582

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test